Monday January 24-th, 2022

Oxford-AstraZeneca COVID-19 vaccine produces strong immune responses in older adults Oxford-AstraZeneca COVID-19 vaccine produces strong immune responses in older adults

Almost one million people have taken an experimental coronavirus vaccine developed by China National Pharmaceutical Group (Sinopharm) through the country's emergency use programme, the firm said late on Wednesday. Instead, it looked at safety indic...

Community flu clinic this weekend Community flu clinic this weekend

According to PA Secretary of Health Dr. Rachel Levine, a record-setting almost 13,000 people in the state have been diagnosed with influenza, and that is just the number of people who sought medical assistance, were tested for influenza, and had lab...

Mayo Clinic: 905 staff diagnosed with COVID in past 2 weeks

The Midwestern states have been particularly hard hit by the recent round of the Govt-19 case uprising - the governor of Minnesota announced new measures this week to help control the spread and the governor of Wisconsin declared a new state of emerg...

CDC strongly recommends that people not travel for Thanksgiving CDC strongly recommends that people not travel for Thanksgiving

The United States reported 143,408 new COVID-19 cases Wednesday, a record daily increase since the onset of the COVID-19 pandemic in the country, CDC said on Thursday. If celebrating indoors, it recommends that Americans open windows and put fans i...

How people reacted to Pfizer, Moderna declaring their COVID-19 vaccines work How people reacted to Pfizer, Moderna declaring their COVID-19 vaccines work

According to researchers, during the Phase 2 trials, the vaccine showed similar immune responses across all the three age groups - 18-55, 56-69, and 70 and over. "It's an important point here, in terms of comparing this vaccine to, for instance, the ...

Pfizer Will Seek FDA Authorization for COVID-19 Vaccine 'Within Days' Pfizer Will Seek FDA Authorization for COVID-19 Vaccine 'Within Days'

If granted, the Pfizer and BioNTech vaccine would be the first shot based on a new mRNA technology to receive FDA authorization. The results suggest good news for seniors: Experts had anxious about the fact that vaccines tend to be less effecti...

Smokeout offers reasons to quit Smokeout offers reasons to quit

In fact, today there are more former smokers than current smokers in Florida. Considering the alternatives - lung cancer, lip cancer and cancers of the mouth, throat and digestive tract - it's not so hard to consider quitting, right? "About one i...

Oxford COVID vaccine promising in elderly Oxford COVID vaccine promising in elderly

Volunteers got two doses of the vaccine or a placebo, and no serious side effects related to the AZD1222 vaccine were reported . "To show this vaccine technology is able to induce these responses, in the age group most at risk from severe COVID-19...

Oxford scientists expect COVID-19 vaccine data by Christmas Oxford scientists expect COVID-19 vaccine data by Christmas

The Sputnik V data from Russian Federation is even more encouraging for Oxford because, like their technology, the vaccine uses a harmless adenovirus to shuttle Covid antigens into the body, proving the approach works in principle. With the vaccine s...

Pfizer-BioNTech vaccine deliveries could start 'before Christmas' Pfizer-BioNTech vaccine deliveries could start 'before Christmas'

Sahin added that the US Food and Drug Administration could grant emergency-use of the vaccine in December and the European Union will give conditional approval in the second half of December. It showed that the vaccine was more than 90 percent effect...

Rutgers wants you to join J&J's COVID-19 vaccine clinical trial Rutgers wants you to join J&J's COVID-19 vaccine clinical trial

Researchers say the Lancet phase two findings , based on 560 healthy adult volunteers, are "encouraging". Johnson & Johnson is in phase three of its clinical research study to test Janssen's COVID-19 vaccine, and Rutgers is looking to enroll as ma...

California’s Newsom still on hot seat for dinner party California’s Newsom still on hot seat for dinner party

Dustin Corcoran , CEO of the California Medical Association, and Janus Norman , the group's lobbyist and senior vice president, joined Newsom and several other guests November 6 at the French Laundry, an exclusive restaurant in Napa County.

Japan health ministry to monitor health of early COVID-19 vaccine recipients Japan health ministry to monitor health of early COVID-19 vaccine recipients

This primary endpoint was reached once 170 positive COVID-19 cases had been detected in the large cohort. According to Pfizer , its results show that its vaccine, which requires two doses, is 95 per cent effective beginning 28 days after the first...

Coronavirus immunity could last for years, according to new study Coronavirus immunity could last for years, according to new study

But for now, researchers are celebrating this reassuring early data. Ramasamy told The Guardian that the "robust antibody and T-cell responses" they saw in the group of older people were encouraging. Sinovac's Phase 1 trial began in April with 14...

US COVID-19 deaths surpass 2,50,000 mark as infections surge US COVID-19 deaths surpass 2,50,000 mark as infections surge

Mizoram on Tuesday recorded 32 new Covid-19 cases, taking its tally past 3,500 to 3,513. The number of coronavirus hospitalizations topped 76,000 on Tuesday, the highest figure since the pandemic began. The Midwest remains the hardest-hit region ba...

Jackson County reports two more COVID-19 deaths; 108 new cases Jackson County reports two more COVID-19 deaths; 108 new cases

According to the Livingston County Health Department, since just October 30th, the number of confirmed and probable cases in the county has nearly doubled from 2,205 to 3,953, while hospitalizations have increased from 148 to 170. This is a developin...

Coronavirus immunity could 'last for years,' new study suggests Coronavirus immunity could 'last for years,' new study suggests

However, in a striking piece of information which throws new light at the situation, a team of researchers from Howard Hughes Medical Institute, Rockefeller University, New York, have found that rather than depleting entirely, the virus-fighting anti...

181 new cases of COVID-19, new public health orders start today 181 new cases of COVID-19, new public health orders start today

As of November 14, 2020 when other provincial and national numbers were available, Saskatchewan's per capita rate was 197,545 people tested per million population. Fifty-two people are receiving inpatient care - 27 in Saskatoon, six in North Central,...

Rutgers University looks for participants in coronavirus vaccine trial Rutgers University looks for participants in coronavirus vaccine trial

On Wednesday, the company's CEO, Alex Gorsky, said during the Washington Economic Club event that until vaccines and therapeutics can be widely distributed, the public would have to rely on public health measures to control the spread of coronavirus,...

Public Health reports 40 COVID-19 new cases since November 13

According to the Livingston County Health Department, since just October 30th, the number of confirmed and probable cases in the county has nearly doubled from 2,205 to 3,953, while hospitalizations have increased from 148 to 170. "However, the ongoi...

Bharat Biotech’s Covaxin now in Phase III trials Bharat Biotech’s Covaxin now in Phase III trials

Trial volunteers will receive two intramuscular injections approximately 28 days apart. India is the second-worst hit by COVID-19 with almost 9 million cases [File: Adnan Abidi/Reuters] Last week, drugmakers Pfizer and BioNTech said their experimen...

Five New COVID-19 Cases in Mason County Wednesday

Just three weeks ago, the two counties had a rate of 168 new cases per 100,000 residents, down significantly from the 573 cases per 100,000 reported August 4, the first week of the thermographic. "We estimate that somewhere between 40% and 80% of the...

Expert Views: Pfizer ends COVID-19 trial with 95% efficacy Expert Views: Pfizer ends COVID-19 trial with 95% efficacy

His comments came after Pfizer and BioNTech on Monday said that their vaccine candidate was found to be more than 90 per cent effective in preventing the disease in interim analysis of data. "The Commission has secured to date at least 1.2 billio...

Alberta adds 991 new COVID-19 cases Alberta adds 991 new COVID-19 cases

Alberta's UCP government has stated several times that the provincial app was tied into the province's contact tracing network, and that's why the federal app couldn't be adopted. Between October 2 and November 17, there has only been one instance wh...

WHO takes aim at cervical cancer to reduce cases, deaths WHO takes aim at cervical cancer to reduce cases, deaths

The World Health Organisation (WHO) on November 17 launched its Global Strategy to Accelerate the Elimination of Cervical Cancer , an initiative which prioritises vaccination, screening and treatment of the disease. There are safe and effective HP...

IN CASE YOU MISSED IT